Radiation Oncology/Therapy: Page 53

IBA reports revenue rebound in 2020

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) bounced back with growth of 10.4% in revenues in 2020 after reporting reduced revenues for the first half of the year due to challenges presented by the COVID-19 pandemic.

March 24, 2021

Study evaluates safety of new liver cancer treatment

By AuntMinnie.com staff writers

Boston Scientific announced that its TheraSphere radioembolization treatment is safe and effective for patients with hepatocellular carcinoma, according to a 25 March presentation at the annual meeting of the Society of Interventional Radiology.

March 24, 2021

Novartis touts phase III prostate cancer study results

By AuntMinnie.com staff writers

Novartis is highlighting results from a phase III study that has investigated the efficacy and safety of Lu-177 PSMA-617, a radioligand therapy for patients with prostate-specific membrane antigen-positive metastatic prostate cancer.

March 22, 2021

New radiotracer for neuroendocrine tumors appears safe

By Will Morton

A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine.

March 22, 2021

Sirtex launches study to assess SIR-Spheres for HCC

By AuntMinnie.com staff writers

Radiation oncology firm Sirtex Medical said it has received U.S. Food and Drug Administration approval to begin a multicenter trial to assess its SIR-Spheres yttrium-90 microspheres as a treatment for unresectable advanced hepatocellular carcinoma (HCC).

March 21, 2021

FDA OK's Boston Scientific's TheraSphere Y-90 microspheres

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's TheraSphere yttrium-90 (Y-90) glass microspheres for the treatment of hepatocellular carcinoma.

March 18, 2021

Akesis radiation therapy system cleared

By AuntMinnie.com staff writers

Radiation therapy developer Akesis announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its Akesis Galaxy RTi gamma stereotactic radiosurgery system for treating brain diseases and brain cancer.

March 17, 2021

Radformation releases rad therapy contouring software

By AuntMinnie.com staff writers

Radiation oncology automation firm Radformation has released AutoContour, an artificial intelligence-based image segmentation software for radiation therapy contouring.

March 16, 2021

Immuno-PET shows tumor response to therapy

By AuntMinnie.com staff writers

Immuno-PET imaging illuminates a tumor's response to therapy, which could translate into better treatment for patients with cancer, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 14, 2021

ViewRay's COO to step down

By AuntMinnie.com staff writers

The chief operating officer (COO) of image-guided radiation therapy vendor ViewRay is leaving the company effective March 31.

March 14, 2021

Mevion plans to supply pediatric proton center in China

By AuntMinnie.com staff writers

Mevion Medical Systems said it has signed a partnership agreement with Children's Hospital of Fudan University in Shanghai and Shanghai Fosun Healthcare to create its first pediatric proton therapy center in China.

March 14, 2021

AI reduces FDG dose on PET imaging

By Kate Madden Yee

An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquired at two-thirds of the standard radiopharmaceutical dose and produce diagnostically effective images, according to a study published March 9 in EJNMMI Physics.

March 11, 2021

Previous Page

Page 53 of 464

Next Page